Raúl Córdoba

Raúl Córdoba Alcalá (13 March 1924 – 17 May 2017) was a Mexican football goalkeeper who played for Mexico in the 1950 FIFA World Cup. Córdoba played for the 1951 Club Atlas squad that won the 1951 league championship. He also played for Club San Sebastián de León, Club Deportivo Oro, and Deportivo Toluca in his career. Córdoba died May 17, 2017, at the age of 93. Provided by Wikipedia
Showing 1 - 20 results of 36 for search 'Raul Cordoba', query time: 0.05s Refine Results
  1. 1
    Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations

    Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations by Concepción Boqué, Silvia Sánchez-Ramón, Raúl Córdoba, Carol Moreno, Elena Cabezudo

    Published 2023-10-01
    Get full text
    Article
  2. 2
    PB2699: CONSENSUS FROM AN EXPERT PANEL ON THE CURRENT MANAGEMENT OF SECONDARY IMMUNODEFICIENCY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN SPAIN

    PB2699: CONSENSUS FROM AN EXPERT PANEL ON THE CURRENT MANAGEMENT OF SECONDARY IMMUNODEFICIENCY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN SPAIN by Concepción Boqué, Silvia Sánchez-Ramón, Raul Cordoba, Carol Moreno, Elena Cabezudo Perez

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Management of psoriasis-like rash associated with idelalisib monotherapy in a patient with refractory follicular lymphoma: a case report

    Management of psoriasis-like rash associated with idelalisib monotherapy in a patient with refractory follicular lymphoma: a case report by Salma Machan, Carlos Plaza, Yosmar Pérez-González, Maria Rodriguez-Pinilla, Luis Requena, Raul Cordoba

    Published 2020-02-01
    Get full text
    Article
  4. 4
    PB2325: VALIDATION OF THE TRAIL SCORE TO PREDICT TOXICITY IN PATIENTS WITH DLBCL RECEIVING R-CHOP-LIKE THERAPY

    PB2325: VALIDATION OF THE TRAIL SCORE TO PREDICT TOXICITY IN PATIENTS WITH DLBCL RECEIVING R-CHOP-LIKE THERAPY by Juan Carlos Caballero, Alberto Lopez-Garcia, Daniel Morillo, Maria Angeles Perez Saenz, Pilar Llamas, Raul Cordoba

    Published 2023-08-01
    Get full text
    Article
  5. 5
    PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES

    PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES by Alberto Lopez Garcia, Ester Macia, Sandra Gomez-Talavera, Eva Castillo-Bazan, Daniel Morillo, Borja Ibañez, Raul Cordoba

    Published 2023-08-01
    Get full text
    Article
  6. 6
    Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients

    Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients by Jon Salmanton-García, Francesco Marchesi, Federico Itri, Francesca Farina, Martin Hoenigl, Raúl Córdoba, Shaimma El-Ashwah, Alessandro Busca, Marianna Criscuolo, Oliver A. Cornely, Livio Pagano

    Published 2023-11-01
    Get full text
    Article
  7. 7
    Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin’s Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient

    Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin’s Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient by Alberto Lopez-Garcia, Laura Solan, Beatriz Alvarez, Juan Carlos Caballero, Javier Cornago, Laura Pardo, Francisco Javier Diaz de la Pinta, Raul Cordoba, Maria Rodriguez-Pinilla

    Published 2023-07-01
    Get full text
    Article
  8. 8
    P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE

    P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-... by Michael Roost Clausen, David Belada, Fritz Offner, Sven de Vos, Joshua Brody, Kim Linton, Sylvia Snauwaert, Raul Cordoba, Jun Wu, Irina Bykhovski, Liwei Wang, Ali Rana, Lorenzo Falchi

    Published 2023-08-01
    Get full text
    Article
  9. 9
    Primary Effusion Lymphoma, Multicentric Castleman’s Disease, and Kaposi’s Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report

    Primary Effusion Lymphoma, Multicentric Castleman’s Disease, and Kaposi’s Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report by Juan Carlos Caballero, Laura Pardo, Maria Socorro Rodriguez-Pinilla, Miguel Angel Piris, Beatriz Alvarez, Laura Solan, Javier Cornago, Jose Luis Lopez-Lorenzo, Pilar Llamas, Raul Cordoba, Alberto Lopez-Garcia

    Published 2023-05-01
    Get full text
    Article
  10. 10
    PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA (OLYMPIA-5)

    PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA... by Umberto Vitolo, Elizabeth H. Phillips, Aránzazu Alonso Alonso, Michele Merli, Ashish Risal, Manjusha Namuduri, Biyi Shen, Dina Flink, Min Zhu, Sushmita Mukherjee, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Raul Cordoba

    Published 2023-08-01
    Get full text
    Article
  11. 11
    Feasibility of Telemedicine in the Management Strategy of Patients With Lymphoma Amid the COVID-19 Pandemic in Spain: Prospective Observational Study

    Feasibility of Telemedicine in the Management Strategy of Patients With Lymphoma Amid the COVID-19 Pandemic in Spain: Prospective Observational Study by Raul Cordoba, Alberto Lopez-Garcia, Daniel Morillo, Maria-Angeles Perez-Saenz, Elham Askari, Rosa Elena Prieto, Eva Castillo Bazan, Pilar Llamas Sillero, Antonio Herrero Gonzalez, Jorge Short Apellaniz, Marta del Olmo, Javier Arcos

    Published 2023-11-01
    Get full text
    Article
  12. 12
    P079: PROCTCAE as a patient-reported outcome measurement (PROM) questionaire in patients with Hodgkin Lymphoma captures different adverse events profile than those reported by physicians

    P079: PROCTCAE as a patient-reported outcome measurement (PROM) questionaire in patients with Hodgkin Lymphoma captures different adverse events profile than those reported by phys... by Sergio Ramos-Cillan, Eva Castillo, Miriam Riesco, Antonio Herroro, Adriana Pascual, Alberto Lopez-Garcia, Maria Angeles Perez, Daniel Morillo, Alham Askari, Elena Prieto, Pilar Llamas, Javier Becares, Carla Barriocanal, Marta Del Olmo, Jorge Short, Javier Arcos, Raul Córdoba

    Published 2022-10-01
    Get full text
    Article
  13. 13
    PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY

    PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY by Caterina Buquicchio, Jon Salmanton-García, Francesco Marchesi, Federico Itri, Caroline Besson, Sonia Martín-Pérez, Julio Dávila-Valls, Luana Fianchi, Laman Rahimli, Giuseppe Tarantini, Federica Irene Grifoni, Jorge Labrador, Raul Cordoba, Alberto Lopez-Garcia, Nicola Stefano Fracchiolla, Francesca Farina, Oliver A. Cornely, Livio Pagano

    Published 2023-08-01
    Get full text
    Article
  14. 14
    P1098: A PHASE II, OPEN-LABEL, MULTICENTER STUDY OF CAPIVASERTIB, A POTENT, ORAL PAN-AKT INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (CAPITAL)

    P1098: A PHASE II, OPEN-LABEL, MULTICENTER STUDY OF CAPIVASERTIB, A POTENT, ORAL PAN-AKT INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (CAPITAL) by Daniel Hodson, Geoffrey Shouse, Ho-Jin Shin, Antonio Salar Silvestre, Sabela Bobillo Varela, Vincent Ribrag, Nicol Macpherson, Raul Cordoba, Jin Seok Kim, John Radford, Stephanie Guidez, Alex F. Herrera, Franck Morschhauser, Dachelle Johnson, Macarena Izuzquiza, Nisha Sambamurthy, Alessandra Forcina, Gullu Gorgun, Robert Chen, Anas Younes, Michael Wang, Wong Seog Kim

    Published 2023-08-01
    Get full text
    Article
  15. 15
    P1689: REAL-WORLD EVIDENCE OF USING TELEMEDICINE TO CAPTURE ELECTRONIC PROM IMPROVES QUALITY OF LIFE ASSESSMENT, HEALTHCARE RESOURCES MANAGEMENT AND OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA

    P1689: REAL-WORLD EVIDENCE OF USING TELEMEDICINE TO CAPTURE ELECTRONIC PROM IMPROVES QUALITY OF LIFE ASSESSMENT, HEALTHCARE RESOURCES MANAGEMENT AND OVERALL SURVIVAL IN PATIENTS WI... by Sergio Ramos, Natalia Barreras, Gabriela Salvatierra, Anna Carolina Miranda Castillo, Laura Bermejo, Pilar Beltran, Daniel Naya, Elena Gonzalez, Maria Yuste, Adriana Pascual, Eva Castillo, Miriam Riesco, Celia Urrutia, Antonio Herrero, Alberto Lopez-Garcia, Maria Angeles Perez Saenz, Daniel Morillo, Pilar Llamas, Javier Becares, Carla Barriocanal, Marta DEL Olmo, Jorge Short, Javier Arcos, Raul Cordoba

    Published 2023-08-01
    Get full text
    Article
  16. 16
    Artículo especial por el Día Mundial del Riñón: Las sociedades científicas españolas ante la guía ESC 2021 de prevención de la enfermedad vascular: generalizar la medida de la albuminuria para identificar el riesgo vascular y prevenir la enfermedad vascular

    Artículo especial por el Día Mundial del Riñón: Las sociedades científicas españolas ante la guía ESC 2021 de prevención de la enfermedad vascular: generalizar la medida de la albu... by Alberto Ortiz, Borja Quiroga, Javier Díez, Francisco Javier Escalada San Martín, Leblic Ramirez, Manuel Pérez Maraver, M. Lourdes Martínez-Berganza Asensio, José Ángel Arranz Arija, José Luis Alvarez-Ossorio Fernández, Raúl Córdoba, Franscisco Brotons Muntó, María Jesús Cancelo Hidalgo, Joan Carles Reverter, Chamaida Plasencia-Rodríguez, Juana Carretera Gómez, Carlos Guijarro, M. del Mar Freijo Guerrero, Patricia de Sequera

    Published 2023-03-01
    Get full text
    Article
  17. 17
    The Spanish Scientific Societies before the ESC 2021 guidelines on vascular disease prevention: Generalizing the measurement of albuminuria to identify vascular risk and prevent vascular disease

    The Spanish Scientific Societies before the ESC 2021 guidelines on vascular disease prevention: Generalizing the measurement of albuminuria to identify vascular risk and prevent va... by Alberto Ortiz, Borja Quiroga, Javier Díez, Francisco Javier Escalada San Martín, Leblic Ramirez, Manuel Pérez Maraver, M. Lourdes Martínez-Berganza Asensio, José Ángel Arranz Arija, José Luis Alvarez-Ossorio Fernández, Raúl Córdoba, Franscisco Brotons Muntó, María Jesús Cancelo Hidalgo, Joan Carles Reverter, Chamaida Plasencia-Rodríguez, Juana Carretera Gómez, Carlos Guijarro, M. del Mar Freijo Guerrero, Patricia de Sequera

    Published 2023-03-01
    Get full text
    Article
  18. 18
    Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2 by Francisco Javier Candel, Pablo Barreiro, Miguel Salavert, Alfonso Cabello, Mario Fernández-Ruiz, Pedro Pérez-Segura, Jesús San Román, Juan Berenguer, Raúl Córdoba, Rafael Delgado, Pedro Pablo España, Ignacio Alberto Gómez-Centurión, Juan María González del Castillo, Sarah Béatrice Heili, Francisco Javier Martínez-Peromingo, Rosario Menéndez, Santiago Moreno, José Luís Pablos, Juan Pasquau, José Luis Piñana, on behalf of the MODUS Investigators (Adenda)

    Published 2023-06-01
    Get full text
    Article
  19. 19
    Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study

    Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study by Mariana Bastos-Oreiro, Antonio Gutierrez, Almudena Cabero, Javier López, Paola Villafuerte, Ana Jiménez-Ubieto, Raquel de Oña, Adolfo De la Fuente, Belén Navarro, Javier Peñalver, Pilar Martínez, Carmen Alonso, María Infante, Raúl Córdoba, Blanca Perez-Montero, Jaime Pérez de Oteyza, Sonia González de Villambrosio, Paula Fernández-Caldas, Raquel del Campo, Daniel García Belmonte, Javier Diaz-Gálvez, Antonio Salar, Juan-Manuel Sancho

    Published 2024-03-01
    Get full text
    Article
  20. 20
    Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

    Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study by Isabel Regalado-Artamendi, Ana Jiménez-Ubieto, José Ángel Hernández-Rivas, Belén Navarro, Lucía Núñez, Concha Alaez, Raúl Córdoba, Francisco Javier Peñalver, Jimena Cannata, Pablo Estival, Keina Quiroz-Cervantes, Rosalía Riaza Grau, Alberto Velasco, Rafael Martos, Amalia Domingo-González, Laurentino Benito-Parra, Elvira Gómez-Sanz, Javier López-Jiménez, Arturo Matilla, María Regina Herraez, María José Penalva, Julio García-Suárez, José Luis Díez-Martín, Mariana Bastos-Oreiro

    Published 2021-03-01
    Get full text
    Article

Search Tools: